Healthcare / Health Information ServicesSwiss
$1.04
-0.01 (-0.95%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-4.9M · quality 77.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$39M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-35.1%
↓Gross Margin
47.0%
↓Debt/Equity
0.30
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.2%
FCF CAGR
—
FCF margin
-8.3%
FCF / Net income
0.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $58.7M · net income $-15.4M · FCF $-4.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $58.7M | $58.7M | $56.8M | $57.1M | $59.0M |
| Net Income | $-15.4M | $-15.4M | $-28.1M | $-7.1M | $-76000.00 |
| EBITDA | $-6.0M | $-6.0M | $-18.2M | $3.0M | $9.5M |
| EPS | — | — | -1.39 | -0.30 | -0.27 |
| Gross Margin | 47.0% | 47.0% | 45.4% | 44.3% | 46.1% |
| Operating Margin | -7.7% | -7.7% | -12.4% | -11.9% | -8.1% |
| Net Margin | -26.2% | -26.2% | -49.5% | -12.4% | -0.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.30 | 0.30 | 0.41 | 0.27 | 0.48 |
| Current Ratio | 1.25 | 1.25 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.9M | $-4.9M | $-4.0M | $-7.0M | $-7.0M |
| Returns | |||||
| ROE | -35.1% | -35.1% | -71.6% | -9.6% | -0.1% |
| Valuation | |||||
| EV/EBITDA | — | — | — | 62.16 | 43.89 |
| P/B | 0.88 | 0.88 | 1.25 | 2.38 | 7.07 |
| Growth & Yield | |||||
| Revenue Growth | 3.4% | 3.4% | -0.5% | -3.3% | — |
| EPS Growth | — | — | -368.0% | -10.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-48.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.39 → n/d
Residual
-48.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.